You are here

Novel Protein Array Based on Binary Coded Microchips

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N/A
Agency Tracking Number: 1R43CA093060-01
Amount: $97,573.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2001
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
5431-C AVENIDA ENCINAS
CARLSBAD, CA 92008
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 HERVE LECALVEZ
 () -
Business Contact
Phone: (760) 431-1263
Email: FERNANDEZ@ACTIVEMOTIF.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): The overall experimental approach of this
proposal is targeted to design an innovative format for arraying proteins.
Instead of using the common glass slide or nitrocellulose membrane to spot
proteins onto, we proposed to use a silica microchip. There are two advantages
of using these chips. First, each chip has its own unique identification code
that will be used to track and detect the protein bound to the chip, an
antibody in this proposal. Second, the size of the microchip allows for
performing the binding of the coded antibody to its protein counterpart in
suspension, such as in a cell extract. The studies described in this
application will determine the feasibility of this approach for designing small
antibody arrays. We will determine whether antibodies coupled to the silica
chip can recognize biotinylated proteins in a cell extract. The
antibody/antigen complexes will be captured on a streptavidin-coated slide
allowing for reading the binary code of the chips by using a flatbed scanner.
This technology will be designed for making small antibody arrays for
diagnostic purposes or the study of a pathway. It would also offer a cheap
alternative to high-tech equipment required for using protein arrays.
PROPOSED COMMERCIAL APPLICATIONS:
DNA arrays has come as the first analytical breakthrough in high-throughput gene regulation analysis, but of the proteome requires a different approach to develop protein biochips.Closing the gap between genotrucs and proteomics is the next scientific challenge. and this proposal aims to build this bridge. The first application will be for designing small antibody strays for diagnostic purposes or the study of a pathway. Further development will lead to the design of a novel system for the identification of protein interaction. Both the equipment and detection method software is expected to be significantly cheaper than the current systems. The protein chip commercial field is as large as the DNA array field.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government